Does Rallies show Form 4 insider transactions for OABI?

Yes. Rallies tracks OABI insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is OABI research on Rallies investment advice?

No. Rallies provides research, data, and educational context for OABI. It does not provide personalized investment advice.

OABI (OmniAb, Inc. Common Stock) Stock Analysis - Insider Trades

OmniAb, Inc. Common Stock (OABI) is a publicly traded Healthcare sector company. As of May 21, 2026, OABI trades at $2.60 with a market cap of $331.99M and a P/E ratio of -5.55. OABI moved +9.28% today. Year to date, OABI is +39.46%; over the trailing twelve months it is +67.53%. Its 52-week range spans $1.22 to $4.87. Analyst consensus is strong buy with an average price target of $7.50. Rallies surfaces OABI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading OABI stock inside the company?

Recent OABI insider activity includes FOEHR MATTHEW W sold 19.24K, GUSTAFSON KURT A sold 6.91K, Berkman Charles S sold 7.16K, Berkman Charles S sold 9.67K, and GUSTAFSON KURT A sold 9.30K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

OABI Key Metrics

Key financial metrics for OABI
Metric	Value
Price	$2.60
Market Cap	$331.99M
P/E Ratio	-5.55
EPS	$-0.46
Dividend Yield	0.00%
52-Week High	$4.87
52-Week Low	$1.22
Volume	3.13K
Avg Volume	0
Revenue (TTM)	$28.94M
Net Income	$-54.29M
Gross Margin	0.00%

Recent OABI Insider Trades

FOEHR MATTHEW W sold 19.24K (~$28.67K) on Apr 7, 2026.
GUSTAFSON KURT A sold 6.91K (~$10.30K) on Apr 7, 2026.
Berkman Charles S sold 7.16K (~$10.66K) on Apr 7, 2026.
Berkman Charles S sold 9.67K (~$16.54K) on Feb 18, 2026.
GUSTAFSON KURT A sold 9.30K (~$15.90K) on Feb 18, 2026.

Latest OABI News

OmniAb Inc Q1 Revenue Seen at $5.69M, Full-Year Forecast Cut 13% — May 6, 2026
OmniAb Secures $3B in Milestones, Launches OmniUltra, Cuts Q4 Expenses to $24.1M — Mar 5, 2026
OmniAb Forecasts $10M Q4 Revenue, $0.09 EPS Loss and Analysts' $7.33 Target — Mar 3, 2026

OABI Analyst Consensus

5 analysts cover OABI: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $7.50.

Common questions about OABI

Who is trading OABI stock inside the company?: Recent OABI insider activity includes FOEHR MATTHEW W sold 19.24K, GUSTAFSON KURT A sold 6.91K, Berkman Charles S sold 7.16K, Berkman Charles S sold 9.67K, and GUSTAFSON KURT A sold 9.30K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for OABI?: Yes. Rallies tracks OABI insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is OABI research on Rallies investment advice?: No. Rallies provides research, data, and educational context for OABI. It does not provide personalized investment advice.